CLICK HOLDINGS LIMITED FORM OF UNDERWRITING AGREEMENTUnderwriting Agreement • October 10th, 2024 • Click Holdings Ltd. • Services-employment agencies • New York
Contract Type FiledOctober 10th, 2024 Company Industry Jurisdiction
RAYTECH HOLDING LIMITED UNDERWRITING AGREEMENTUnderwriting Agreement • November 17th, 2023 • Raytech Holding LTD • Household appliances • New York
Contract Type FiledNovember 17th, 2023 Company Industry Jurisdiction
UNUSUAL MACHINES, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • August 7th, 2023 • Unusual Machines, Inc. • Radio & tv broadcasting & communications equipment • New York
Contract Type FiledAugust 7th, 2023 Company Industry JurisdictionUnusual Machines, Inc., a Puerto Rico corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell an aggregate of [●] shares (“Shares”) of the Company’s common stock $0.01 par value per share (the “Common Stock”) (each a “Firm Share” and one or more, the “Firm Shares”) to the several underwriters (such underwriters, for whom Maxim Group LLC (“Maxim” or the “Representative”) is acting as representative, the “Underwriters” and each an “Underwriter”). The Company has also agreed to grant to the Representative on behalf of the Underwriters an option (the “Option”) to purchase up to an additional [●] Shares (the “Option Shares.” The Company has also agreed to issue to the Representative the Underwriters’ Warrants (as defined in Section 1(c)), which together with the Common Stock underlying such warrants are referred to herein as the “Underwriters’ Securities.” The Firm Shares and the Option Shares, together with the Underwriters’ Securities ar
GREENWICH LIFESCIENCES, INC. UNDERWRITING AGREEMENT ____________ Shares of Common StockUnderwriting Agreement • December 15th, 2020 • Greenwich LifeSciences, Inc. • Pharmaceutical preparations • New York
Contract Type FiledDecember 15th, 2020 Company Industry JurisdictionGREENWICH LIFESCIENCES, INC., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom Aegis Capital Corp. is acting as representative (the “Representative”), an aggregate of ____________ authorized but unissued shares of common stock, par value $0.001 per share, (the “Common Stock”) of the Company (the “Firm Shares”). The Company also proposes to sell to the Underwriters, upon the terms and conditions set forth in Section 4 hereof, up to an additional ____________ shares of Common Stock (the “Option Shares”). The Firm Shares and the Option Shares are hereinafter collectively referred to as the “Shares” or the “Securities”.
REED’S, INC. UNDERWRITING AGREEMENT 18,750,000 Shares of Common StockUnderwriting Agreement • November 23rd, 2020 • Reed's, Inc. • Bottled & canned soft drinks & carbonated waters • New York
Contract Type FiledNovember 23rd, 2020 Company Industry JurisdictionReed’s, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom Roth Capital Partners, LLC is acting as the representative (the “Representative”), an aggregate of 18,750,000 authorized but unissued shares (the “Firm Shares”) of common stock, par value $0.0001 per share (the “Common Stock”), of the Company. The Company also proposes to sell to the Underwriters, upon the terms and conditions set forth in Section 4 hereof, up to an additional 2,812,500 shares of Common Stock (the “Option Shares”). The Firm Shares and the Option Shares are hereinafter collectively referred to as the “Shares”.
UNDERWRITING AGREEMENTUnderwriting Agreement • May 29th, 2012 • Monmouth Real Estate Investment Corp • Real estate investment trusts • New York
Contract Type FiledMay 29th, 2012 Company Industry JurisdictionMonmouth Real Estate Investment Corporation, a Maryland corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell an aggregate of [•] shares (the “Firm Shares”) of the Company’s [•]% Series B Cumulative Redeemable Preferred Stock, $0.01 par value per share, (the “Preferred Stock”) to the several underwriters named in Schedule I hereto (collectively, the “Underwriters”), for whom BMO Capital Markets Corp., a Delaware corporation (“BMOCM”), is acting as representative (the “Representative”). The Company has also agreed to grant to the Underwriters an option to purchase up to an additional [•] shares of Preferred Stock (the “Option Shares”). The Firm Shares and the Option Shares are hereinafter collectively referred to as the “Shares.”